Sanofi India Limited

Company Profile

Sanofi India Limited had its IPO on under the ticker symbol SANOFI.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Sanofi India Limited has a staff strength of 2,651 employees.

Stock update

Shares of Sanofi India Limited opened at ₹7092 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹6961.35 - ₹7173, and closed at ₹7145.95.

This is a +0.51% increase from the previous day's closing price.

A total volume of 1,989 shares were traded at the close of the day’s session.

In the last one week, shares of Sanofi India Limited have increased by +0.5%.

Sanofi India Limited's Key Ratios

Sanofi India Limited has a market cap of ₹164.59 billion, indicating a price to book ratio of 9.311 and a price to sales ratio of 4.918.

In the last 12-months Sanofi India Limited’s revenue was ₹28.06 billion with a gross profit of ₹15.65 billion and an EBITDA of ₹7.51 billion. The EBITDA ratio measures Sanofi India Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sanofi India Limited’s operating margin was 25.67% while its return on assets stood at 24.51% with a return of equity of 52.79%.

In Q2, Sanofi India Limited’s quarterly earnings growth was a positive 2.1% while revenue growth was a positive 1%.

Sanofi India Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

28.6225

PEG

Its diluted EPS in the last 12-months stands at ₹249.69 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sanofi India Limited’s profitability.

Sanofi India Limited stock is trading at a EV to sales ratio of 4.6723 and a EV to EBITDA ratio of 15.1282. Its price to sales ratio in the trailing 12-months stood at 4.918.

Sanofi India Limited stock pays annual dividends of ₹194 per share, indicating a yield of 2.73% and a payout ratio of 77.69%.

Balance sheet and cash flow metrics

Total Assets

₹14.98 billion

Total Liabilities

₹7.25 billion

Operating Cash Flow

₹434.00 million

Capital Expenditure

₹148 million

Dividend Payout Ratio

77.69%

Sanofi India Limited ended 2024 with ₹14.98 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹14.98 billion while shareholder equity stood at ₹7.24 billion.

Sanofi India Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹7.25 billion in other current liabilities, 230000000.00 in common stock, ₹7.01 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹140.00 million and cash and short-term investments were ₹4.50 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Sanofi India Limited’s total current assets stands at ₹10.33 billion while long-term investments were ₹0 and short-term investments were ₹16.00 million. Its net receivables were ₹1.26 billion compared to accounts payable of ₹3.30 billion and inventory worth ₹4.12 billion.

In 2024, Sanofi India Limited's operating cash flow was ₹434.00 million while its capital expenditure stood at ₹148 million.

Comparatively, Sanofi India Limited paid ₹0.78 in dividends in 2024.

Other key metrics

Current Trading Price

₹7145.95

52-Week High

₹7587.9502

52-Week Low

₹5069.6777

Analyst Target Price

₹

Sanofi India Limited stock is currently trading at ₹7145.95 per share. It touched a 52-week high of ₹7587.9502 and a 52-week low of ₹7587.9502. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹7051.61 and 200-day moving average was ₹6135.55 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6057.4% of the company’s stock are held by insiders while 2444.3% are held by institutions.